A REAL-WORLD ASSESSMENT OF ASTHMA EXACERBATIONS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB

被引：0
|
作者：
Ke, X.
Kavati, A.
Wertz, D.
Huang, Q.
Wang, L.
Willey, V.
Stephenson, J.
Ortiz, B.
Panettieri, R., Jr.
Corren, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P211
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [41] Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma
    Tadrous, Mina
    Khuu, Wayne
    Lebovic, Gerald
    Stanbrook, Matthew B.
    Martins, Diana
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    Gomes, Tara
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (01) : 59 - +
  • [42] Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
    Barnes, Neil
    Menzies-Gow, Andrew
    Mansur, Adel H.
    Spencer, David
    Percival, Fran
    Radwan, Amr
    Niven, Rob
    JOURNAL OF ASTHMA, 2013, 50 (05) : 529 - 536
  • [43] Real-World Patterns of Pharmacotherapeutic Management of Asthma Patients With Exacerbations in the Spanish National Health System
    Hurtado, Isabel
    Garcia-Sempere, Anibal
    Peiro, Salvador
    Bengoetxea, Asier
    Prieto, Jesus Luis
    Sanfelix-Gimeno, Gabriel
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [44] Real-world assessment of clinical remission in asthma with biologics
    Howarth, Peter
    Lim, Kaiser
    Corbridge, Tom
    Lee, Lydia
    Barman, Hannah
    Manoharan, Mithun
    Simsek, Safak
    Wagner, Tyler
    Deb, Arijita
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [45] Dupilumab Asthma ADVANTAGE-EU: Real-World Evidence on the Association Between Dupilumab and Use of Corticosteroid and Asthma Exacerbations in Patients With Severe Asthma in Europe
    Bourdin, A.
    Canonica, G.
    Virchow, J.
    Jacob-Nara, J.
    Borsos, K.
    Stanford, R. H.
    Pandit-Abid, N.
    Wang, Z.
    Soler, X.
    Huynh, L.
    Kalia, S.
    Duh, M.
    Cheng, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [46] BENRALIZUMAB REAL-WORLD EFFECTIVENESS ON EXACERBATIONS AMONG US SPECIALIST-TREATED PATIENTS WITH SEVERE ASTHMA: DATA FROM CHRONICLE
    Panettieri, R.
    Lugogo, N.
    Moore, W.
    Chipps, B.
    Jepson, B.
    Zhou, W.
    Ambrose, C.
    Genofre, E.
    Carstens, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S30 - S31
  • [47] Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic
    Kirchnerova, Olga Ruzickova
    Valena, Tomas
    Novosad, Jakub
    Terl, Milan
    Bystron, J.
    Chlumsky, J.
    Kindlova, D.
    Klosova, J.
    Krcmova, I
    Parakova, Z.
    Pohunek, P.
    Popelkova, P.
    Sedlak, V
    Vanik, P.
    Vernerova, E.
    Zatloukal, J.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2019, 36 (01): : 34 - 43
  • [48] Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
    Casale, Thomas B.
    Luskin, Allan T.
    Busse, William
    Zeiger, Robert S.
    Trzaskoma, Benjamin
    Yang, Ming
    Griffin, Noelle M.
    Chipps, Bradley E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01): : 156 - +
  • [49] Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
    Barthwal, Madhusudan
    Dutta, Vijay
    Bhattacharya, Parthasarthi
    Vora, Agam
    Kotnis, Mangala
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [50] Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada
    Lee, Jason K.
    Amin, Suvina
    Erdmann, Michelle
    Kukaswadia, Atif
    Ivanovic, Jelena
    Fischer, Aren
    Gendron, Alain
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 725 - 735
12345